Trupanion (NASDAQ:TRUP) EVP Steve Weinrauch Sells 6,674 Shares

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) EVP Steve Weinrauch sold 6,674 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $22.00, for a total value of $146,828.00. Following the completion of the transaction, the executive vice president directly owned 78,062 shares of the company’s stock, valued at $1,717,364. The trade was a 7.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Trupanion Stock Performance

NASDAQ TRUP opened at $22.17 on Wednesday. The stock has a market capitalization of $967.06 million, a price-to-earnings ratio of 37.58 and a beta of 1.45. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $57.88. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The stock has a 50-day moving average of $24.39 and a 200 day moving average of $29.50.

Trupanion (NASDAQ:TRUPGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. The company had revenue of $384.05 million during the quarter, compared to analysts’ expectations of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.Trupanion’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.03) EPS. Sell-side analysts anticipate that Trupanion, Inc. will post 0.53 EPS for the current fiscal year.

Institutional Investors Weigh In On Trupanion

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Federated Hermes Inc. acquired a new stake in shares of Trupanion in the third quarter valued at approximately $33,000. Kelleher Financial Advisors acquired a new stake in shares of Trupanion in the third quarter valued at approximately $74,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Trupanion in the fourth quarter valued at approximately $64,000. Parallel Advisors LLC increased its holdings in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in shares of Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 478 shares during the last quarter.

Analysts Set New Price Targets

A number of equities analysts have commented on TRUP shares. Cantor Fitzgerald reduced their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Stifel Nicolaus reduced their target price on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a report on Tuesday, March 31st. Finally, Bank of America reduced their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $42.25.

View Our Latest Research Report on TRUP

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Featured Articles

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.